Paul S.

Paul S. currently serves as Vice President of Enterprise Portfolio Management at Nxera Pharma, a role held since June 2020, where responsibilities include managing the Sosei Heptares drug discovery and development portfolio while supporting commercial and business development activities. Previously, Paul held positions such as Director of Programme Management at Gyroscope Therapeutics and R&D Project/Portfolio Manager at Mission Therapeutics. Experience at Takeda includes roles as Project Portfolio Manager and various leadership positions focused on molecular biology. Paul’s academic credentials include a Ph.D. in Gene/Genetic Therapy from the University of Cambridge, alongside qualifications in Strategic R&D Management from INSEAD and Project Management Professional certification from the Project Management Institute.